Bergmann Anthony
CHIEF FINANCIAL OFFICER
Bergmann Anthony has filed 5 SEC Form 4 filings (11 transaction rows) across 1 company, with disclosures dating back to 2026. 5 of those filings fall inside the rolling window. Most recent filing: Jun 30, 2026.
On the most recent filing, Bergmann Anthony is listed as CHIEF FINANCIAL OFFICER at CAPRICOR THERAPEUTICS, INC. Inside the rolling window, Bergmann Anthony reported no open-market purchases and 5 open-market sales totaling $2.3M in CAPR. The largest disclosed transaction in the window is a sale of 25,000 CAPR shares on May 1, 2026, worth $793K.
Companies traded
Other insiders at CAPR
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$2.3M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Bergmann Anthony made?
Bergmann Anthony has filed 5 SEC Form 4 filings (11 transaction rows) across 1 company since 2026.
Which companies does Bergmann Anthony trade?
Bergmann Anthony has filed SEC Form 4 disclosures for 1 company, including CAPR.
When was Bergmann Anthony's most recent SEC Form 4 filing?
Bergmann Anthony's most recent SEC Form 4 filing on Tracefour is dated Jun 30, 2026.
What is Bergmann Anthony's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Bergmann Anthony is listed as CHIEF FINANCIAL OFFICER.
What is Bergmann Anthony's total buy and sell value in the current window?
Inside the rolling retention window, Bergmann Anthony bought $0 and sold $2.3M based on SEC Form 4 filings.
What was Bergmann Anthony's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 25,000 CAPR shares on 2026-05-01, worth $793K, per SEC Form 4 filings.